Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anthony Alfonso
Institution:
Indiana University School of Medicine
Observed institutions:
Indiana University Bloomington,
Indiana University Indianapolis,
Indiana University School of Medicine,
Indiana University
ORCID:
0000-0001-9045-6498
Observed ORCID:
0000-0001-9045-6498
OpenAlex ID:
A5047963496
Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study
2024
·
Alexander P Landry
, Justin Z Wang
, et al.
·
Neuro-Oncology
·
20
Single-Institution Comparative Study of Magnetic Resonance–Guided Laser Interstitial Thermal Therapy and Open Corpus Callosotomy
2023
·
Josue D. Ordaz
, Ramana Vishnubhotla
, et al.
·
World Neurosurgery
·
13
Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion
2023
·
Nur P. Damayanti
, M. Reza Saadatzadeh
, et al.
·
Scientific Reports
·
1
PDF
Comparison by immunotherapy agent of real-world outcomes with chemoimmunotherapy in first-line extensive-stage small cell lung cancer.
2026
·
Anthony Alfonso
, Paresh Kumar
, et al.
·
Journal of Clinical Oncology
Demographics and outcomes of individuals with young-onset small cell lung cancer.
2026
·
Paresh Kumar
, Anthony Alfonso
, et al.
·
Journal of Clinical Oncology
Impact of lung cancer screening in patients diagnosed with small cell lung cancer.
2026
·
Paresh Kumar
, Emmalee E. Kiser
, et al.
·
Journal of Clinical Oncology
A new era of immunotherapy: Comparison of real-world outcomes in limited-stage small cell lung cancer.
2026
·
Brook Marie Lobsiger
, Paresh Kumar
, et al.
·
Journal of Clinical Oncology
PDF
Exth-43. Targeting the Dna Damage Response Through Combination Mdm2 and Akt Inhibitor Therapy Improves Temozolomide Effectiveness in Chemo-resistant Glioblastoma
2023
·
Jenna Koenig
, Barbara Bailey
, et al.
·
Neuro-Oncology
PDF
Abstract 5498: SHP2 inhibition enhances antitumor effect of mirdametinib in a pediatric brain tumor model bearing CDC42SE2BRAF fusion by rewiring the proteome and phosphoproteome landscape
2023
·
Nur P. Damayanti
, Anthony Alfonso
, et al.
·
Cancer Research
Multi-combination therapy for temozolomide-resistant GBM: identification of temozolomide/small molecule inhibitor combinations that target the MDM2/p53 and PI3K-AKT/mTOR networks
2021
·
Anthony Alfonso
, Barbara J. Bailey
, et al.
·
Proceedings of IMPRS
PDF
Show more works
View as search
Works count:
10
Citation count:
34
H-index:
2
I10-index:
2
Year
Topic
Type